Title: New Developments in Childhood Asthma

Speaker: Daniel Jackson, MD – Tenured Professor, Allergy, Immunology & Rheumatology, Jackson Research Group, University of Wisconsin – Madison  

As a result of participating in this educational activity, learners as members of the healthcare team will be able to:

1. Identify the risks, short- and long-term, associated with asthma exacerbations

2. Describe the rationale and data supporting the use of single-inhaler therapy with low-dose ICS formoterol in mild asthma

3. Explain the current and emerging data for biologics in asthma treatment in children and adolescents


Session date: 
09/23/2021 - 7:30am to 8:30am CDT
Via Zoom
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Daniel Jackson, MD